Babies born after prenatal drug exposure don’t all look the same, and many look perfectly healthy at birth. The visible signs depend heavily on which substance was involved, how much was used, and how far along the pregnancy was. Some newborns show obvious physical differences within hours, while others appear typical at first and develop noticeable symptoms days later. The medical term for withdrawal symptoms in newborns is neonatal abstinence syndrome (NAS), though alcohol exposure produces its own distinct set of physical features.
Signs of Opioid Withdrawal in Newborns
Opioids, including heroin, fentanyl, and prescription painkillers, cause the most recognizable set of withdrawal symptoms. These babies often look agitated and uncomfortable in ways that are hard to miss. Their muscles are noticeably tight, a condition called increased muscle tone, which makes their limbs feel stiff rather than having the relaxed, floppy quality typical of newborns. They tremble visibly, sometimes even while sleeping.
Their cry is often the first thing people notice. It’s high-pitched, shrill, and difficult to soothe, distinctly different from a normal newborn cry. These babies also have trouble feeding. They may suck excessively on a pacifier or their fists but then struggle to coordinate actual feeding, leading to poor weight gain, spitting up, or projectile vomiting. Loose, watery stools are common, and the combination of frequent diarrhea and sensitive skin often produces severe diaper rash or raw, broken-down skin in the diaper area.
Other visible signs include sneezing, nasal stuffiness, sweating, blotchy or mottled skin, and a rapid breathing rate. These babies sleep very little, often less than one to two hours after a feeding before waking again. The overall impression is of a baby who is deeply uncomfortable and cannot settle.
When Symptoms Appear and How Long They Last
Withdrawal symptoms typically start between one and three days after birth, though they can appear as late as five to ten days depending on the substance. Heroin tends to cause earlier onset, while methadone withdrawal may take longer to surface. This delayed appearance means a baby can look fine in the hospital and develop visible symptoms after going home.
Most babies experience withdrawal symptoms for an average of 20 days, but some continue showing signs for four to six months. Alcohol withdrawal, which is less common but does occur, can begin within hours of birth and produce symptoms lasting up to 18 months. Hospitals use a scoring system that tracks things like crying intensity, sleep duration, tremors, muscle tone, breathing rate, and feeding problems to determine how severe the withdrawal is and whether the baby needs medical treatment beyond supportive care.
Fetal Alcohol Syndrome: Distinct Facial Features
Alcohol exposure during pregnancy produces the most visually distinctive and permanent physical changes. Unlike opioid withdrawal, which resolves over time, fetal alcohol syndrome (FAS) causes structural differences in facial development that persist throughout life. Doctors look for three specific features when making a diagnosis.
The first is a smooth philtrum, the vertical groove between the nose and upper lip. In most people, this groove has a defined ridge on each side, but in children with FAS it appears flat or barely visible. The second is a thin upper lip, where the red portion of the lip is noticeably narrow. The third is short eye openings (palpebral fissures), meaning the distance from the inner corner to the outer corner of each eye is significantly smaller than average for the child’s age.
Babies with FAS also tend to be smaller overall, with lower birth weight and a smaller head circumference. These facial features can be subtle in newborns and often become more apparent as the child grows into toddlerhood. Not every alcohol-exposed baby develops all three features. The full spectrum of alcohol-related effects ranges from children with clearly recognizable facial differences to those with no visible signs but significant behavioral or learning challenges.
Cocaine and Stimulant Exposure
Babies exposed to cocaine or methamphetamine before birth tend to be physically small. They frequently have low birth weight, reduced body length, and smaller head circumference compared to unexposed newborns. Cocaine causes intense constriction of blood vessels in the fetus, which can restrict blood flow during critical periods of development. In rare cases, this vascular disruption leads to more serious structural problems, including limb abnormalities, kidney or urinary tract malformations, and intestinal damage.
Unlike opioid-exposed babies, stimulant-exposed newborns don’t always show dramatic withdrawal symptoms. They may seem jittery, irritable, or difficult to console, but the presentation is generally less intense and less predictable than opioid withdrawal. Methamphetamine exposure has been linked to abnormal behavioral patterns and possible growth restriction in some studies, though these findings are still being clarified.
What These Babies Look Like Day to Day
In practice, many substance-exposed newborns look like any other baby in the nursery, especially in the first hours after birth. There is no single “look” that reliably identifies prenatal drug exposure. The most visible signs tend to be behavioral rather than structural: the inconsolable crying, the trembling, the inability to sleep, the frantic sucking followed by poor feeding. Skin changes like severe diaper rash, blotchy coloring, or scratch marks from their own flailing movements are common but not unique to drug exposure.
Size is one of the more consistent physical differences. Across nearly all substance categories, exposed babies tend to be smaller than average at birth. But small size alone is not diagnostic of anything, since many factors affect birth weight.
The term “drug baby” itself carries significant stigma, and healthcare providers use more specific language like neonatal opioid withdrawal syndrome or prenatal substance exposure. This isn’t just a matter of politeness. The vague label obscures the fact that outcomes vary enormously depending on the substance, the timing and amount of exposure, and the quality of care the baby receives after birth. Many of these children, with appropriate medical support and stable caregiving, develop normally and show no lasting visible effects of their early exposure.